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Summary
Objective: Based on function and developmental fate, cartilage tissue can be broadly classified into two types: transient (embryonic or
growth-plate) cartilage and permanent cartilage. Chondrocytes in transient cartilage undergo terminal differentiation into hypertrophic cells,
induce cartilage-matrix mineralization, and eventually disappear and are replaced by bone. On the other hand, chondrocytes in permanent
cartilage do not differentiate further, do not become hypertrophic, and persist throughout life at specific sites, including joints and tracheal
rings. While many studies have described differences in structure, matrix composition and biological characteristics between permanent and
transient cartilage, it is poorly understood how the fates of permanent and transient cartilage are determined. Previous studies demonstrated
that chondrocytes isolated from permanent cartilage have the potential to express markers of the mature hypertrophic phenotype once grown
in culture, suggesting that cell hypertrophy is an intrinsic property of all chondrocytes and must be actively silenced in permanent cartilage
in vivo. These silencing mechanisms, however, are largely unknown. In this paper, we first review nature of chondrocytes in transient and
permanent cartilages and then report the cloning and characterization of a novel variant of ets transcription factor chERG, hereafter called
C-1-1, which might be involved in regulation of permanent cartilage development.
Design: For cloning of a novel variant of chERG (C-1-1), we isolated RNA from the cartilaginous femur or tibiotarsus of Day 17 chick embryos
and processed it for reverse transcription-polymerase chain reaction (RT-PCR) with the primers from sequences upstream and downstream
of the 81 and 72 bp segments alternatively-spliced in mammals. For investigation of function of chERG and C-1-1, we over-expressed
chERG or C-1-1 in cultured chick chondrocytes or the developing limb of chick embryo using a retrovirus (RCAS) system, and examined the
phenotype changes in the infected chondrocytes or the infected limb elements.
Results: C-1-1 is an alternative and novel variant lacking the 27 amino acids segment of chERG that has been reported previously. C-1-1
is preferentially expressed in developing articular cartilage, whereas chERG is preferentially expressed in growth plate cartilage. Growth of
articular chondrocytes in culture was accompanied by decreasing C-1-1 expression after several passages, while expression of hypertrophic
markers increased. Expression of C-1-1 in cultured chondrocytes inhibited cell hypertrophy, alkaline phosphatase activity, and cartilage
matrix mineralization. In contrast, over-expression of chERG promoted chondrocyte maturation and mineralization.
Conclusion: Our data demonstrate for the first time that chERG and C-1-1 play distinct roles in skeletogenesis and may have crucial roles
in the development and function of transient and permanent cartilages. © 2001 OsteoArthritis Research Society International
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Cartilage is a unique connective tissue, which is character-
ized by abundant cartilage-matrix mainly composed of type
II collagen and high molecular weight proteoglycan, and
little or no vascularization. Based on location and histology,
cartilage tissue has been classified into several types1. In
addition to these classifications, cartilage tissue can be
roughly subdivided into two types: transient cartilage and
permanent cartilage. Most of the embryonic cartilaginous
skeleton, the epiphyseal growth-plates of long bones, and
the cartilaginous callus forming at fracture sites can all be
classified as transient cartilage. These cartilages are
responsible for bone formation, growth and repair; their
cells undergo proliferation, maturation, hypertrophy andS41mineralization, and are eventually replaced by bone cells
and tissue. Articular, tracheal and other small cartilage
structures can instead be classified as permanent cartilage.
The cells in these cartilage tissues maintain a stable
phenotype, do not undergo maturation and hypertrophy,
and persist throughout life. In doing so, these cartilage can
exert a continuous function, including providing resilience
to joints and tracheal rings and allowing normal bio-
mechanical movements.
Skeletal structures in the developing limb represent an
excellent model to investigate the genesis of permanent
and transient cartilage. During limb skeletogenesis,
mesoderm-derived chondrogenic precursor cells condense
at sites of future bone forming areas, differentiate into a
seemingly uniform population of chondrocytes, and give
rise to primitive cartilaginous skeletal anlagen. Soon after,
the numerous chondrocytes constituting the shaft of these
cartilaginous structures undergo further differentiation.
They proliferate actively, synthesize large amounts of
cartilage extracellular matrix, and become hypertrophic
S42 M. Iwamoto et al.: Role of ERG in cartilage development(also called terminal differentiation) (Fig. 1)2. Hypertrophic
chondrocytes produce type X collagen and alkaline phos-
phatase, and induce cartilage-matrix-mineralization3.
The calcified matrix is invaded by capillaries and bone
marrow cells, and is finally replaced by bone1. The cyto-
differentiation of chondrocytes progresses from epiphyses
toward the diaphysis, so that the first area to undergo
hypertrophy and marrow and blood invasion is the incipient
diaphysis itself. Once the initial diaphysis is ossified, typical
growth plates appear at each metaphysis/epiphysis; the
growth plates are organized in distinct zones, including
resting, proliferative, prehypertrophic, hypertrophic, and
mineralizing zone, and allow the maturation and cyto-
differentiation process of chondrocytes to continue until
skeletal growth stops at the end of puberty.
In contrast, chondrocytes forming at the epiphyseal ends
of limb cartilaginous skeletal elements exhibit a more stable
phenotype. They remain biosynthetically active, undergo
only a limited number of cell cycles, and never progress
through maturation under normal conditions. These cells
thus display a permanent state and produce, organize and
maintain the articular tissue. Articular chondrocytes are
uniformly small and round in size, and are surrounded by a
very abundant matrix2.
Extensive effort has been directed at clarifying the struc-
ture, expression patterns and function of cartilage matrix
molecules. In addition, there has been much progress in
understanding the development of transient growth plate
chondrocytes, in particular the roles played by fibroblast
growth factors and their receptors, hedgehog proteins,
retinoid signals and bone morphogenetic proteins4–8. In
sharp contrast, the regulation of development and mainten-
ance of permanent cartilage is still larely unclear. How do
articular chondrocytes acquire and retain a stable immature
phenotype? How do articular chondrocytes avoid matura-
tion, hypertrophy and mineralization which characterize
transient growth plate chondrocytes?ALL CHONDROCYTES HAVE THE INTRINSIC ABILITY TO PROCEED
TO TERMINAL DIFFERENTIATION
It has been suggested that lack of cell hypertrophy and
matrix mineralization in permanent cartilage is due to
negative regulation by microenvironmental cues and
mechanisms. We previously investigated whether chondro-
cytes in permanent cartilage have the potential to express
the terminal differentiation phenotype9. We isolated
chondrocytes from free end and costochondral junction of
rib cartilage in 4-week-old rabbits. The free end cartilage of
ribs does not calcify for a long time in vivo and can be
considered as permanent cartilage. When these cells were
maintained in micromass pellet culture, they eventually
produced alkaline phosphatase and induced mineralization
at levels comparable with those of growth plate chondro-
cytes reared under similar conditions9. We10 and others11
reported that chick and human articular chondrocytes syn-
thesize type X collagen when maintained in suspension
culture. The induction of type X collagen synthesis was also
demonstrated by Castagnola et al.12 in cultures of imma-
ture chondrocytes isolated from lower portion of chick
embryo sterna. In addition to the in vitro cultures, chondro-
cytes in permanent cartilage occasionally express terminal
differentiation-related markers in vivo. Osteoarthritis in
articular cartilage is characterized by severe destruction
of cartilage matrix without inflammation. In this case, it is
often accompanied by expression of various terminal
differentiation-related markers, including type X collagen13,
osteonectin14 and MMP1315. The findings suggest first.
that permanent chondrocytes have the potential to proceed
toward terminal differentiation, and second. that this ability
is suppressed under normal healthy circumstances but can
be activated under experimental or pathological conditions;
the latter include (a) destruction of the normal pericellular
microenvironment by enzymatic digestion for the purpose
of in vitro culture studies and (b) a pathological process of
matrix degradation during osteoarthritis. These obser-
vations lead us to conclude that permanent chondrocytes
possess powerful mechanisms which prevent accidental or
pathological maturation. These mechanisms probably rep-
resent complex interplays between cell-derived processes
and microenvironmental influences. Regrettably, these
mechanisms are largely unknown. If available, this infor-
mation would provide important clues on the development
of permanent and transient cartilage and would also have
important medical ramifications.Fig. 1. Scheme depicting the alternative developmental fates of
chondrocytes. A number of matrix genes diferentially expressed
in chondrocytes at different stages of cyto-differentiation is
indicated.EXPRESSION OF CHICK ETS-RELATED GENES IN CARTILAGE
Phenotypic changes accompanying cell differentiation
result from activation and inactivation of specific genes.
Therefore, to understand the genesis of permanent carti-
lage, it would be of importance to identify transcription
factors involved in the regulation of gene expression during
skeletogenesis. It has been recently shown that the tran-
scription factor, chick ets-related gene, named chERG is
first expressed in cartilaginous mesenchymal conden-
sations and then at sites of future joints in the early
developing chick limb16–18. Based on these studies, we
hypothesized that chERG may be involved in the genesis
and function of articular chondrocytes and pursued the
function of this gene.
ERG (ets-related gene) belongs to the ets family of
transcription factors, which share the ETS domain, a con-
served 85-amino acid region that binds ets motifs contain-
ing the core recognition sequence 5′-GGAA-3′19. Three
Osteoarthritis and Cartilage Vol. 9 Suppl. A S43Fig. 2. Amino acid sequences and expression of chERG variants in chick embryo cartilages. (a) Amino acid sequences of chERG and C-1-1.
Ets DNA binding domain (EDB) is underlined. C-1-1 lacks the 27 amino acid segment (boxed region) and contains an amino acid substitution
from G to R as a result of splicing. (b) Schematic representation of chERG and C-1-1 showing the location of the alternatively spliced 81 bp
segment located approximately 200 bp upstream of the EDB. Location of primers used in RT-PCR is indicated by arrows. Antigenic sites of
anti chERG and antichERG/C-1-1 are also indicated. (c) Electrophoretic analysis of RT-PCR products obtained with RNA isolated either from
articular cartilage (AC) or growth-plate cartilage (GC) of Day 17 chick embryo tibiotarsus. (d) Immunohistochemical detection of chERG and
C-1-1 proteins in Day 17 chick embryo tibiotarsus longitudinal sections. The antibodies used were: a rabbit antiserum raised against a
peptide PLPHLTSDDVDKALQNSPRLMH corresponding to the 27 amino acid region present only in chERG that we prepared(anti-chERG);
and rabbit affinity-purified antibodies to human ERG-1/ERG-2 (Santa Cruz Biotechnology) raised against a peptide corresponding to
C-terminus 20 amino acid residues of human ERG-1 that is present in every ERG-variant and is highly conserved in chick (anti-chERG/C-
1-1). The specificity of antibodies was confirmed by immunoblot analysis and ELISA assay (not shown). AC: articular cartilage, GC:
growth-plate cartilage, FC: fibrous cartilage.major splice variants of mammalian ERG have been
reported and named ERG1, ERG2 and ERG320,21. The
longest variant, ERG3 is also called p55erg, and is about
480 amino acids long. In comparison, ERG-2 lacks a 24
amino acid segment in the central portion of the protein
upstream of the ETS domain, and ERG-1/p49 erg lacks
both the 24 amino acid segment and an adjacent 27 amino
acid segment. All ERG variants transactivate reporter con-
structs containing ets response elements, but it is not clear
whether they have different functions20,21. CHERG shows
homology to mammalian ERG3/p55erg.
To investigate whether chERG is expressed at late
stages of chick limb skeletogenesis, we isolated RNA from
the cartilaginous femur or tibiotarsus of Day 17 chick
embryos and processed it for reverse transcription-
polymerase chain reaction (RT-PCR). The PCR primers
used in this study (indicated as arrows in Fig. 2b) were from
sequences upstream and downstream of the 81 and 72 bp
segments alternatively-spliced in mammals. We obtained
two products of 473 and 392 bp (Fig. 2c). Sequence
analysis revealed that the 473 bp product encoded the
previously described chERG, while the 392 bp product
encoded an alternative and novel variant lacking the 27
amino acids segment, which is shown in the box in Fig. 2a.
We named this avian variant C-1-1. No additional chERG
variants were obtained by 5′ and 3′ RACE analysis of
cartilage samples (not shown).If chERG or C-1-1 is involved in articular cartilage
development, one would expect to see a difference in
expression level of these variants between articular carti-
lage and growth plate cartilage. When RNA was isolated
from the articular layer and from the underlying growth
plate of Day 17 tibiotarsus and processed for RT-PCR, the
473 and 392 bp products were obtained in both samples
(Fig. 2c). However, the intensity of the 392 bp product from
articular chondrocyte RNA (Fig. 2c, AC) was much stronger
than that from growth plate chondrocyte RNA (Fig. 2c, GC),
while the intensity of 473 products was similar in the two
groups (Fig. 2c, 473 chERG). The data indicate that C-1-
1(392 bp product) is expressed at higher levels in articular
than growth plate chondrocytes.
To identify the chondrocyte population(s) expressing
chERG and/or C-1-1, longitudinal sections of Day 17 chick
embryo tibiotarsus were processed for immunohistochemi-
cal examination. We used two antisera for this study. One
antiserum (anti-chERG/C-1-1) recognizes the C-terminal
portion of both chERG and C-1-1. The other antiserum
(anti-chERG) is raised against the 27 amino acid segment
present in chERG and absent in C-1-1 and thereby only
recognizes chERG protein (Fig. 2b). Staining with the
anti-chERG/C-1-1 antiserum produced a strong signal in
both the articular chondrocyte layer and the pre-
hypertrophic zone of growth plate (Fig. 2d, anti-chERG/C-
1-1). By contrast, the chERG-specific antiserum produced
S44 M. Iwamoto et al.: Role of ERG in cartilage developmentstrong staining in the pre-hypertrophic zone only (Fig. 2d,
anti-chERG), suggesting that the signal in articular
cartilage layer is largely due to C-1-1. Thus, C-1-1 is
preferentially expressed in developing articular cartilage,
while chERG is expressed in the articular layer and pre-
hypertrophic zone of growth plate.
When articular chondrocytes are placed in culture, they
eventually become hypertrophic. Thus, we determined
whether there is an inverse relationship between C-1-1
expression and the acquisition of the hypertrophic pheno-
type by permanent chondrocytes in vitro. Articular chon-
droyctes were isolated from the articular layer of tibiotarsus
in Day 17 chick embryo, and serially passaged at weekly
intervals. After several passages, the articular chondro-
cytes expressed the type X collagen gene (Fig. 3a) and
produced alkaline phosphatase (Fig. 3b), indicating that the
cells had reached the hypertrophic stage after prolonged
cultures. RT-PCR analysis revealed that expression of
C-1-1 gradually decreased with culture time and passage
number (Fig. 3c). Thus, the decrease in C-1-1 expression is
indeed accompanied by acquisition of the hypertrophic
phenotype in articular chondrocytes, suggesting that C-1-1
is a negative regulator of hypertrophy in chondrocytes.


Fig. 3. Expression of hypertrophic markers and chERG variants in
articular chondrocytes in vivo and in vitro. Articular chondrocytes
were isolated from articular layer of tibiotarsus in Day 17 chick
embryo, and cultured as described previously10. Total RNA and
whole cell lysates were prepared from: (i) articular layer of tibio-
tarsus in Day 17 chick embryo (AC); (ii) twice passaged 3-week-
old cultures (P2); and (iii) three times passaged 4-week-old cul-
tures (P3). Total RNA was used for the analyses of gene
expression of type X collagen (a) and chERG and C-1-1 (c). Cell
lysates were used for measurement of APase activity (b).DIFFERENTIAL EFFECTS OF CHERG AND C-1-1 IN CHONDROCYTES
To elucidate the function of C-1-1 and chERG in
chondrocytes, we over-expressed these molecules in
chondrocytes, using the chick retrovirus (RCAS) system22.
We isolated immature chondrocytes from Day 17 chick
embryo sternum, infected them with RCAS virus encoding
chERG or C-1-1 or with insert-less virus, and maintained
the cultures for up to 5–6 weeks with weekly subculturing
(passage 1–6). Sternal, rather than tibiotarsus, chondro-
cytes were used because the cells can be isolated as
homogenous populations; in addition, the cells continue
and complete their maturation process in culture23,24.
Chondrocytes infected with chERG or C-1-1 virus produced
several-fold more chERG or C-1-1 protein than control
cultures infected with insert-less virus, as determined by
immunoblot using the anti-chERG/C-1-1 antibody (data not
shown). Morphological examination of 1-week-old control
cultures (passage #1) revealed that the chondrocytes had
the expected morphological characteristics; most of the
cells loosely attached to the substrate and were round in
shape, while the remaining cells were polygonal (Fig. 4, P1
RCAS). In 6 week-old control cultures (passage #5), how-
ever, all the cells were firmly attached to the substrate and
many cells displayed a flat and fibroblastic morphology, a
sign that these cells had lost or were losing their differen-
tiated phenotype (Fig. 4 P5 RCAS). In contrast, in cultures
infected with chERG virus, most of the cells displayed
a healthy polygonal morphology both at early and late
passages (Fig. 4 P1 and P5 RCAS-chERG). The C-1-1-
expressing cells (Fig. 4/RCAS-C-1-1) were similarly
healthy and polygonal, but their average size was smaller
than that of chERG-expressing cells.
To examine the stage of differentiation of these cultures,
total RNA was isolated from similar cultures at passage #1,
2 and 5 and was processed for Northern blot analysis.
Gene expression of aggrecan remained fairly constant over
time and passage number in RCAS, RCAS-chERG and
RCAS-C-1-1- cultures (Fig. 5a, aggrecan); a similar stable
proteoglycan expression was seen after histochemical
staining with Alcian blue (Fig. 5b, AB). Both control cultures
and chERG-cultures expressed type X collagen, whileC-1-1- cultures did not (Fig. 5a, type X collagen), indicating
that C-1-1 inhibited progression of terminal differentiation of
chondrocytes but chERG did not. This conclusion was
further supported by histochemical analysis for APase
activity. Control cultures showed high levels of APase
Osteoarthritis and Cartilage Vol. 9 Suppl. A S45activity at passage 2 and 5, while the C-1-1-virus-infected
cultures exhibited no positive APase staining at any time
point examined (Fig. 5b, APase). In addition, virally-driven
C-1-1 expression completely inhibited matrix calcification
determined by von Kossa staining (Fig. 4c). Interestingly,
chERG expression had no inhibitory effects on expression
of hypertrophic phenotype; in fact, it stimulated APase
activity (Fig. 5b APase RCAS-chERG) and matrix calcifi-
cation (Fig. 5c RCAS-chERG). Clearly, C-1-1 and chERG
have distinct biological activities in chondrocytes. Over-
expression of C-1-1 maintains chondrocytes in an imma-
ture state and blocks type X collagen expression and
APase activity. In comparison, chERG promotes expres-
sion of functions associated with chondrocyte maturation,
namely APase activity and mineral deposition in the extra-
cellular matrix. Thus, C-1-1 is a negative regulator of the
hypertrophic phentype whereas chERG promotes it.Fig. 4. Morphology of chondrocytes infected with insertless control
virus, chERG-encoding virus or C-1-1 encoding virus at passage 1
and 5. Primary sternal chondrocytes infected with insert-less
virus (RCAS), chERG encoding virus (RCAS-chERG) or C-1-1-
encoding virus (RCAS-C-1-1) were maintained in monolayer cul-
ture with weekly passages. Phase contrast microphotographs
were taken at 1 week (P1) and 6 week (P5) in culture.A
B
C
Fig. 5. Diverse effects of chERG and C-1-1 on the expression of
hypertrophic phenotype in cultured chondrocytes. Primary sternal
chondrocytes infected with insert-less virus (RCAS), chERG
encoding virus (RCAS-chERG) or C-1-1-encoding virus (RCAS-C-
1-1) were maintained in monolayer culture with weekly passages.
(a) Northern blot analysis to determine gene expression of aggre-
can and type X collagen in passasge 1(P1) through passage 5 (P5)
chondrocyte cultures. (b) Micrographs of microwell cultured
chondrocytes at passage 1 (P1) through passage 6 (P6) pro-
cessed for Alcian blue (pH 1.0) or APase staining. (c) Micro-
graphs of multiwell cultures stained with Von Kossa to reveal
mineralization.POSSIBLE MODE OF ACTION OF CHERG AND C-1-1 IN CARTILAGE
DEVELOPMENT
The preferential expression of C-1-1 in articular chondro-
cytes and its ability to serve as a negative regulator of
hypertrophy both suggest that C-1-1 may normally be a
regulator of permanent cartilage development during skel-
etogenesis. However, the biological activity of C-1-1
described above is not enough to support this hypothesis,
because C-1-1 might be only a negative regulator for
chondrocyte maturation without having necessarily a role in
specification and determination of permanent cartilage.
Articular chondrocytes are surrounded by abundant
amounts of tenascin-C, which probably mediates matrix-
cell surface interactions25,26, while this matrix protein is not
produced by growth plate chondrocytes and is barely
detectable in growth plate cartilage. We have found that
virally-driven expression of C-1-1 induces production of
tenascin-C in chondrocytes in vitro (manuscript submitted).
There have been many factors reported to inhibit expres-
sion of terminal differentiation of chondrocytes in vitro,
including FGF27, PTHrp28 and TGF-β3. However, none of
these factors could induce tenascin-C in chondrocytes (not
shown). Thus, C-1-1 appears to have the unique ability to
induce a trait of articular chondrocytes, in addition to be
able to inhibit expression of the hypertrophic programme.This strongly suggests that C-1-1 may play an important
role in the determination and genesis of articular cartilage.
On the other hand, chERG may be one of the factors
promoting chondrocyte maturation during endochondral
ossification.
The mechanisms underlying the different biological
activities of chERG and C-1-1 are unknown. The 27 amino
acid segment present in chERG and absent in C-1-1 is
located within the negative transcriptional activation
S46 M. Iwamoto et al.: Role of ERG in cartilage developmentdomain described in human ERG321. Therefore the trans-
activation activities of the two factors may be altered by the
absence or presence of this segment. Another possibility is
that more general structural differences are caused in
C-1-1 and chERG by the presence or absence of 27 amino
acid domain. These global structural alternations may
cause changes in physical interactions with other transcrip-
tion factors and in susceptibility to phosphorylation. These
changes could also influence DNA-binding affinity and
sequence recognition specificities.
The target genes of C-1-1 and chERG action in chondro-
cytes remain to be identified. Human ERG-3 has been
reported to bind ets motifs in the promoters of
collagenase-1 and stromelysin 1, and to transactivate the
collagenase 1 gene by interacting with c-Fos/c-Jun com-
plex binding to an adjacent AP-1 site29,30. We have found
that the tenascin-C promoter31 contains a small element
around position -300 which includes an ets consensus site
adjacent to an AP-1 site (unpublished observations). Thus,
C-1-1 may have a similar direct role in the regulation of
tenascin-C gene expression in articular chondrocytes via
interaction with C-1-1/c-Fos/c-jun complexes.References
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